Question:
How does mechanical strain on the right ventricular wall during rowing at low heart rates (60–70 bpm) affect the Aveir VR’s pacing threshold or local myocardial excitability, potentially leading to transient discomfort sensations?
Answer (mechanistic hypothesis & testing plan)
Summary. During low-intensity rowing at 60–70 bpm, longer diastolic filling raises right ventricular (RV) end-diastolic volume and wall stretch. This alters local electromechanical conditions at the Aveir VR fixation site (active-helix in RV endocardium), which can transiently increase capture threshold and/or evoke unusual afferent sensations via stretch‑activated channels. As exercise intensity and heart rate rise (≥80 bpm), diastolic time shortens, filling becomes less extreme and wall strain patterns stabilize; sympathetic tone also increases the perceptual threshold for discomfort. The net effect is resolution of symptoms at higher rates.
Key mechanisms to consider
- Mechano‑electric feedback (MEF): Increased RV wall tension at low HR activates stretch‑activated ion channels (e.g., SACNS), modifying local excitability and potentially increasing the acute capture threshold near the device–tissue interface.
- Contact geometry & micro-motion: With higher preload at low HR, the endocardial surface can deform relative to the device capsule/helix. Micro‑motion or altered contact pressure may momentarily change current density and stimulate nearby mechanosensitive afferents, perceived as “discomfort.”
- Stroke‑volume dominated regime: At 60–70 bpm, rowing output relies more on stroke‑volume augmentation → larger RV volumes and larger longitudinal strain swings; at ≥80 bpm, the system transitions toward rate‑mediated output with smaller per‑beat deformation.
- Autonomic balance: Parasympathetic predominance early in exertion may sharpen interoceptive perception; rising sympathetic drive (≥80 bpm) increases pain/awareness thresholds and can slightly lower myocardial impedance, improving capture uniformity.
- Resonance bands: Low‑frequency cardiac motion (1–1.2 Hz) could align with a device–tissue micro‑oscillation mode; shifting to ≥1.3 Hz may move the system off-resonance, reducing sensation.
Why symptoms at 60–70 bpm?
- Longer diastole → higher RV end‑diastolic volume → greater wall stretch at the fixation site.
- Higher instantaneous capture threshold or altered current dispersion due to geometry/impedance changes.
- Enhanced afferent signaling from endocardial mechanoreceptors during large deformation cycles.
Why improvement at ≥80 bpm?
- Shorter diastolic time → moderated filling → reduced cyclical strain where the device is anchored.
- More stable impedance/contact and current delivery pattern with smaller per‑beat deformation.
- Sympathetic analgesia and a possible shift away from any low‑frequency resonance.
How to test this hypothesis (pragmatic protocol)
- Device interrogation vs. HR tiers: Measure capture thresholds, sensing amplitudes, and impedance at rest, 60–70, and ≥80 bpm (upright & semi‑supine).
- Exercise echo (or cardiac MRI where feasible): Quantify RV volumes and regional strain at those HR tiers; overlay with symptom timing.
- 12‑lead ECG + Holter during rowing ergometer: Look for rate‑dependent changes in QRS morphology or fusion/capture variability.
- Posture/respiratory maneuvers: Evaluate whether venous return shifts (Valsalva, paced breathing) modulate symptoms at fixed HR.
- Programming trial: Temporarily adjust output, pulse width, or rate‑response to assess symptom sensitivity to capture margin.
Clinical note (non‑diagnostic): This is an explanatory framework for discussion with the patient’s electrophysiologist. Personalized evaluation—including device telemetry, imaging, and supervised exercise testing—is essential before any change in therapy.